ArticleCancer immunology, immunotherapy : CII2012

EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells.

Amélie Vézina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.